Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
ZOGENIX, INC. (ZGNX)
Sector: Healthcare; Industry: Biotechnology

Zogenix, Inc., a pharmaceutical company, develops and commercializes transformative therapies to enhance the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome (LGS); and which is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. Zogenix, Inc. was founded in 2006 and is headquartered in Emeryville, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-11-19 GARNER CAM L Director Buy 8,000 $20.13 $161,042 No
2020-11-17 TANNENBAUM RENEE P Director Sell 15,000 $20.74 $311,066 No
2020-05-12 Farfel Gail M EVP/Chief Development Officer Sell 2,573 $28.21 $72,584 No
2020-05-08 Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER Buy 1,000 $25.45 $25,450 No
2020-03-23 WIGGINS MARK C Director Buy 2,500 $20.48 $51,196 No
2020-03-19 FARR STEPHEN J President and CEO Sell 6,158 $18.51 $113,964 Yes
2020-03-18 Galer Bradley S. EVP/Chief Medical Officer Buy 1,000 $19.68 $19,685 No
2020-03-13 GARNER CAM L Director Buy 8,000 $21.83 $174,647 No
2020-01-08 FARR STEPHEN J President and CEO Sell 34,225 $51.89 $1,775,921 Yes
2020-01-02 Smith Michael P EVP, CFO, Treasurer & Sec. Sell 22,500 $51.79 $1,165,340 Yes
2019-12-16 BREITMEYER JAMES B Director Sell 5,000 $50.00 $250,000 Yes
2019-11-25 FARR STEPHEN J President and CEO Sell 34,225 $50.00 $1,711,250 Yes
2019-11-25 Smith Michael P EVP, CFO, Treasurer & Sec. Sell 15,000 $48.00 $720,000 Yes
2019-11-25 BREITMEYER JAMES B Director Sell 5,000 $50.00 $250,000 Yes
2019-08-22 Farfel Gail M EVP/Chief Development Officer Sell 3,446 $52.00 $179,192 No
2019-08-09 Smith Michael P EVP, CFO, Treasurer & Sec. Sell 15,000 $50.00 $750,000 Yes
2019-08-09 WIGGINS MARK C Director Sell 6,250 $50.00 $312,500 Yes
2019-07-03 FARR STEPHEN J President and CEO Sell 34,225 $48.01 $1,643,161 Yes
2019-06-27 Smith Michael P EVP, CFO, Treasurer & Sec. Sell 15,000 $46.32 $694,800 Yes
2019-03-29 HAWLEY ROGER Director Sell 20,700 $55.00 $1,138,500 Yes
2019-03-14 HAWLEY ROGER Director Sell 60,000 $52.99 $3,179,476 No
2019-03-06 TANNENBAUM RENEE P Director Sell 17,503 $50.65 $886,474 Yes
2019-03-01 HAWLEY ROGER Director Sell 4,300 $55.00 $236,500 Yes
2019-03-01 HAWLEY ROGER Director Sell 4,300 $50.00 $215,000 Yes
2019-03-01 GARNER CAM L Director Sell 15,250 $50.00 $762,500 Yes
2019-02-27 GARNER CAM L Director Sell 5,625 $50.00 $281,250 Yes
2019-02-12 GARNER CAM L Director Sell 12,405 $46.85 $581,147 Yes
2019-01-10 FARR STEPHEN J President and CEO Sell 90,313 $45.00 $4,064,085 Yes
2018-12-14 HAWLEY ROGER Director Sell 20,000 $41.35 $826,910 No
2018-11-26 MAST ERLE T Director Sell 1,468 $42.08 $61,772 No

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.